Recent years have witnessed significant advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as promising https://brianglea678757.blogdeazar.com/39301690/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements